Research
The Division of Oncology and Hematology has a long tradition of pioneering research in the field of cancer and its treatment.
All faculty members of the Division participate in the various programs/studies conducted within the Fred & Pamela Buffet Cancer Center.Memberships and Affiliations
The Division has been a main member of the Cancer and Leukemia Group B (CALGB) for Non-Institutional Cooperative trials since 1996, now renamed the Alliance for Clinical Trials in Oncology (Alliance). Alliance is one of four multidisciplinary cooperative adult cancer treatment groups funded by the National Cancer Institute. Each Non-Institutional cooperative group trial focuses on particular areas of cancer research, often collaborating in large-scale clinical trials.
The Division is an active national Research Reporting Center to the Center for International Blood and Marrow Transplant Research. The center holds the contract for the Stem Cell Therapeutic Outcomes Database Health Resources and Service Administration of the US Dept. of Health and Human Services. The center is charged with collecting our institution's program data on all allogeneic hematopoietic cell transplantations performed in the United States under Federal Law. The center forms a research collaboration with the National Marrow Donor Program and the Blood and Marrow Transplant Clinical Trial Network to facilitate observational and interventional research outcomes through a large network of transplant centers. The network is funded by the National Cancer Institute and is a network of transplant institutions/consortia in the United States actively recruiting patients to various clinical protocols in bone marrow and hematopoietic stem cell transplantation.
The Division is a member in the Big Ten Cancer Research Consortium, comprising of the Big Ten universities (Sponsor Investigators) that create a unique team culture to pre-screen large populations in order to identify small, molecularly-enriched subsets. The Division is very active in various Industrial (Pharmaceutical), Non-Intervention and Institutional Investigator-Initiated clinical research trials conducted with NIH Clinical Research Trials around the world.

Nebraska Lymphoma Study Group
The Oncology and Hematology Division is known for the establishment of the Nebraska Lymphoma Study Group. Learn more about this unique collaboration between community oncologists and pathologists and their counterparts at UNMC.
Clinical Research Trial Contacts
Research Topic | Primary Contact |
Bone Marrow Transplant / GVHD | Penny Hardiman, RN |
Brain | Sarah Kirke, RN |
Breast | Shara Graalfs, RN |
Gastrointestinal | Brandie Booker, RN |
GYN/ONC | Pamela Nielsen, RN |
Head and Neck | Jamie Willms, RN; Devi Fitelly, RN |
Leukemia | Rachal Brantley, RN |
Lymphoma / CLL | Maribeth Hohenstein, RN |
Lymphoma/ CLL / Car T-cell | Susan Blumel, RN |
Melanoma | Jamie Willms, RN; Devi Fitelly, RN |
Myeloma / Plasma Cell Dyscrasia | Penny Hardiman, RN |
Myeloproliferative disease (MPD) | Rachal Brantley, RN |
Neuromuscular disease (MDA) | Rachal Brantley, RN |
Thoracic | Jamie Willms, RN; Devi Fitelly, RN |
Sarcoma | Sarah Kirke, RN |